- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Lucid Diagnostics Inc (LUCD)
Lucid Diagnostics Inc stock price live, this page displays NASDAQ LUCD stock exchange data. View the LUCD premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Lucid Diagnostics Inc real time stock price chart below.
What Is the Lucid Diagnostics Inc Stock Price Today?
The Lucid Diagnostics Inc stock price today is 0.3968.
What Is the Stock Symbol for Lucid Diagnostics Inc?
The stock ticker symbol for Lucid Diagnostics Inc is LUCD.
Is LUCD the Same as $LUCD?
$LUCD is a common way to refer to the Lucid Diagnostics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Lucid Diagnostics Inc Trade On?
Lucid Diagnostics Inc is listed and trades on the NASDAQ stock exchange.
Is Lucid Diagnostics Inc a Good Stock to Buy?
Determining whether Lucid Diagnostics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Lucid Diagnostics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LUCD quote. (ISIN: US54948X1090)
What Is the Lucid Diagnostics Inc Stock Price Today?
The Lucid Diagnostics Inc stock price today is 0.3968.
What Is the Stock Symbol for Lucid Diagnostics Inc?
The stock ticker symbol for Lucid Diagnostics Inc is LUCD.
Is LUCD the Same as $LUCD?
$LUCD is a common way to refer to the Lucid Diagnostics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Lucid Diagnostics Inc Trade On?
Lucid Diagnostics Inc is listed and trades on the NASDAQ stock exchange.
Is Lucid Diagnostics Inc a Good Stock to Buy?
Determining whether Lucid Diagnostics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Lucid Diagnostics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LUCD quote. (ISIN: US54948X1090)
0.3968
+0.0154(+4.04%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.3826
0.4300
52 wk Range
0.3030
1.6293
Earnings results expected today
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.38260.4300
52 wk Range
0.30301.6293
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LUCD Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
4.0000
Upside
+908.06%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Form 8K Lucid Diagnostics Inc For: 22 October- Investing.com
Form 8K Lucid Diagnostics Inc For: 22 September- Investing.com
- Form 8K Lucid Diagnostics Inc For: 12 November
- Investing.com
- Form 8K Lucid Diagnostics Inc For: 12 November
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 4.0000
(+908.06% Upside)
Lucid Diagnostics Inc SWOT Analysis
Analyst Outlook | Price targets range from $2.00 to $7.50, reflecting mixed sentiment on Lucid's prospects amid recent test volume fluctuations and revenue challenges |
Financial Hurdles | Despite 40% revenue growth, Lucid faces profitability challenges with negative margins and cash burn, highlighting the importance of securing reimbursement |
Reimbursement Quest | The company nears a crucial Medicare coverage milestone for EsoGuard, which could transform its business model from volume-focused to revenue-driven |
Market Potential | Lucid Diagnostics targets a $25 billion BE-EAC screening market in the US, positioning its EsoGuard/EsoCheck offerings as potential industry standards |
Lucid Diagnostics Inc Earnings Call Summary for Q3/2026
- Q3 revenue of $1.2M missed $1.63M forecast; non-GAAP loss of $0.06/share slightly wider than expected $0.0525 amid reimbursement transition.
- Medicare coverage breakthrough: Novitas paying $1,938.01 per test starting October; record 1,800+ tests performed that month vs 2,871 in entire Q3.
- Cash position strengthened to $33M pro forma after $15M Series C financing; quarterly burn rate improved to $10.2M, lowest in four quarters.
- CEO Aklog says Medicare approval transforms commercialization from 'marathon to sprint'; sales force redirected to Medicare population for 90% margin tests.
- Management expects 'very solid' Q4 with continued Medicare payment growth, though cautioned on holiday seasonality; MolDX pathway for California lab pending.
Last Updated: 11/12/2026, 09:34 AM
Read Full TranscriptEarnings
Latest Release
Nov 12, 2026
EPS / Forecast
-0.06 / -0.05
Revenue / Forecast
1.2M / 1.63M
Compare LUCD to Peers and Sector
Metrics to compare | LUCD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLUCDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.1x | 0.0x | −0.2x | |
PEG Ratio | −0.02 | 0.00 | 0.00 | |
Price / Book | 6.8x | 1.5x | 2.6x | |
Price / LTM Sales | 13.6x | 2.1x | 2.8x | |
Upside (Analyst Target) | - | 75.9% | 60.5% | |
Fair Value Upside | Unlock | 24.5% | 7.8% | Unlock |
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. The company’s flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Lucid Diagnostics (LUCD) Stock Price Today?
The Lucid Diagnostics stock price today is 0.3968 USD.
What Stock Exchange Does Lucid Diagnostics Trade On?
Lucid Diagnostics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Lucid Diagnostics?
The stock symbol for Lucid Diagnostics is "LUCD."
What Is the Lucid Diagnostics Market Cap?
As of today, Lucid Diagnostics market cap is 72.8300M USD.
What Is Lucid Diagnostics's Earnings Per Share (TTM)?
The Lucid Diagnostics EPS (TTM) is -0.46.
From a Technical Analysis Perspective, Is LUCD a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Lucid Diagnostics Stock Split?
Lucid Diagnostics has split 0 times.
What is the current trading status of Lucid Diagnostics (LUCD)?
As of Nov 12, 2026, Lucid Diagnostics (LUCD) is trading at a price of 0.3968 USD, with a previous close of 0.3814 USD. The stock has fluctuated within a day range of 0.3826 USD to 0.4300 USD, while its 52-week range spans from 0.3030 USD to 1.6293 USD.
What Is Lucid Diagnostics (LUCD) Price Target According to Analysts?
The average 12-month price target for Lucid Diagnostics is 4.0000 USD, with a high estimate of 9.5 USD and a low estimate of 2 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +908.06% Upside potential.
What Is the LUCD Premarket Price?
LUCD's last pre-market stock price is 0.4120 USD. The pre-market share volume is 190,260.0000, and the stock has decreased by 0.0306, or 8.0200%.
What Is the LUCD After Hours Price?
LUCD's last after hours stock price is 0.3906 USD, the stock has decreased by 0.0092, or 2.4100%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.